“This decision is an important next step of our collaboration with Denali […] that aims to advance the next generation of [amyloid beta] immunotherapies for the treatment of Alzheimer’s ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Mice deficient in BACE1 (beta-site APP cleaving enzyme 1 ... BACE1 −/− mice also hemizygous for an amyloid precursor protein (APP) transgene lack brain β-amyloid (Aβ) and β-secretase ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

With the first amyloid-targeting drug now approved for ... developing Alzheimer’s dementia with fewer doses than the first generation of antibody-based amyloid therapies. Moreover, it is also ...